21 May 2024
Impact Healthcare REIT plc
("Impact" or the "Company")
Result of 2024 Annual General Meeting
The Board of Impact Healthcare REIT plc (ticker: IHR), the real estate investment trust which gives investors exposure to a diversified portfolio of UK healthcare real estate assets, in particular care homes, announces that at the Company's 2024 Annual General Meeting held today, all resolutions proposed at the AGM were voted on and passed by a poll by the Company's shareholders and the results of the poll, including the proxy votes received, are set out below.
Resolutions 1 to 14 (inclusive) were proposed as ordinary resolutions and resolutions 15 to 18 (inclusive) were proposed as special resolutions.
|
|
Resolution |
Votes For* |
% |
Votes Against |
% |
Total votes validly cast |
Total votes cast as % of issued share capital |
Votes Withheld ** |
|
1 |
Receive the Annual Report and Financial Statements Year 31 December 2023 |
253,990,339 |
98.07% |
5,000,000 |
1.93% |
258,990,339 |
62.50% |
454,356 |
|
2 |
Approve the directors' remuneration policy |
259,266,401 |
99.98% |
62,982 |
0.02% |
259,329,383 |
62.58% |
115,312 |
|
3 |
Approve the directors' remuneration report |
259,268,331 |
99.98% |
61,052 |
0.02% |
259,329,383 |
62.58% |
115,312 |
|
4 |
Approve the Company's Dividend Policy |
259,439,371 |
100.00% |
0 |
0.00% |
259,439,371 |
62.61% |
5,324 |
|
5 |
Re-elect Simon Laffin as a director |
253,685,324 |
99.99% |
18,692 |
0.01% |
253,704,016 |
61.23% |
5,740,679 |
|
6 |
Re-elect Rosemary Boot a director |
259,323,378 |
99.95% |
120,965 |
0.05% |
259,444,343 |
62.61% |
352 |
|
7 |
Re-elect Amanda Aldridge as a director |
256,397,863 |
98.83% |
3,046,479 |
1.17% |
259,444,342 |
62.61% |
353 |
|
8 |
Re-elect Chris Santer as a director |
259,419,355 |
99.99% |
24,988 |
0.01% |
259,444,343 |
62.61% |
352 |
|
9 |
Elect Cedi Frederick as a director |
259,427,432 |
99.99% |
16,911 |
0.01% |
259,444,343 |
62.61% |
352 |
|
10 |
To re-appoint BDO LLP as the Company's auditor |
254,409,647 |
99.99% |
26,900 |
0.01% |
254,436,547 |
61.40% |
5,008,148 |
|
11 |
To authorise the board of directors to determine the auditors remuneration |
259,431,918 |
100.00% |
8,629 |
0.00% |
259,440,547 |
62.61% |
4,148 |
|
12 |
To authorise the continuation of the Company |
259,434,033 |
100.00% |
1,810 |
0.00% |
259,435,843 |
62.61% |
8,852 |
|
13 |
To authorise the Directors to allot shares under section 551 Companies Act 2006 |
259,375,339 |
99.98% |
49,328 |
0.02% |
259,424,667 |
62.61% |
20,028 |
|
14 |
Subject to the passing of resolution 11, to authorise the Directors to allot additional shares under section 551 Companies Act 2006 |
254,376,269 |
98.05% |
5,048,398 |
1.95% |
259,424,667 |
62.61% |
20,028 |
|
15 |
Subject to the passing of resolution 12, to disapply statutory pre-emption rights under section 570 Companies Act 2006 |
240,489,252 |
92.70% |
18,935,415 |
7.30% |
259,424,667 |
62.61% |
20,028 |
|
16 |
Subject to the passing of resolution 13, to disapply statutory pre-emption rights under section 570 Companies Act 2006 |
240,265,205 |
92.61% |
19,167,961 |
7.39% |
259,433,166 |
62.61% |
11,529 |
|
17 |
To authorise the Company to make market purchase of its own ordinary shares |
252,974,475 |
97.52% |
6,427,561 |
2.48% |
259,402,036 |
62.60% |
42,659 |
|
18 |
To permit general meetings to be called on 14 days' notice |
254,380,724 |
98.05% |
5,063,617 |
1.95% |
259,444,341 |
62.61% |
354 |
Every shareholder has one vote for every Ordinary Share held. As at close of business on 17 May 2024, the share capital of the Company consisted of 414,368,169 Ordinary Shares with voting rights. The Company does not hold any shares in Treasury.
In accordance with Listing Rule 9.6.2, copies of all the resolutions passed, other than ordinary business, will be submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
* Includes discretionary votes.
** A vote withheld is not a vote in law and is not counted in the calculation of the votes for or against a resolution.
FOR FURTHER INFORMATION, PLEASE CONTACT:
|
Impact Health Partners LLP Andrew Cowley |
via Maitland/AMO |
|
|
|
|
JTC (UK) Limited - Company Secretary Christopher Gibbons |
0207 409 0181 |
|
|
|
|
H/Advisors Maitland (Communications advisor) James Benjamin |
07747 113 930 |
The Company's LEI is 213800AX3FHPMJL4IJ53.
NOTES:
Impact Healthcare REIT plc acquires, renovates, extends and redevelops high quality healthcare real estate assets in the UK and lets these assets on long-term full repairing and insuring leases to high-quality established healthcare operators which offer good quality care, under leases which provide the Company with attractive levels of rent cover.
The Company aims to provide shareholders with an attractive sustainable return, principally in the form of quarterly income distributions and with the potential for capital and income growth, through exposure to a diversified and resilient portfolio of UK healthcare real estate assets, in particular care homes for the elderly.
The Company's dividend policy is to maintain a progressive dividend that is covered by adjusted earnings.
On this basis, the target total dividend for the year ending 31 December 2024 is 6.95 pence per share*, a 0.18 pence increase over the 6.77 pence in dividends paid or declared per ordinary share for the year ended 31 December 2023.
The Group's Ordinary Shares trade on the main market of the London Stock Exchange, premium segment. The Company is a constituent of the FTSE EPRA/NAREIT index.
* This is a target only and not a profit forecast. There can be no assurance that the target will be met and it should not be taken as an indicator of the Company's expected or actual results.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
